Caracterização de eventos adversos em uma unidade de terapia intensiva neonatal

Ricardo Alexandre Spironello, Roberto Kenji Nakamura Cuman

Resumo

Existem problemas nas unidades hospitalares relacionados a erros de prescrição, medicamentos, procedimentos, eventos adversos (EAs) e medicamentos. Trata-se de um estudo-piloto descritivo realizado na unidade neonatal de um hospital de Maringá, caracterizando as internações de pacientes na UTIN e a ocorrência de EA registrados em prontuários em um hospital privado em Maringá de junho 2016 a março 2017.Foram avaliados indicadores: taxas de mortalidade, ocupação, taxas de permanência e ocorrência de EA. Os dados foram obtidos dos registros de enfermagem nos prontuários de pacientes hospitalizados no setor. Observou-se 607 eventos adversos, sendo 326(53,70%) procedimentos relacionados ao acesso venoso central; 87 (14,33%) cateter central de inserção periférica (PICC); 87 (14,33%) à intubação; 45 (7,41%) para atraso na colocação do cateter vesical; e, 32 (5,27%) para cateter umbilical, dentre outros. Um Melhor acompanhamento do setor deve ser incentivado para evitar a ocorrência de EAs em procedimentos hospitalares, farmacoterapia e interações medicamentosas.

Descritores: Unidade de Terapia Intensiva, Neonatal, Eventos Adversos.

 

Caracterization of adverse events in a neonatal intensive care unit

Abstract: There are problems in hospital units related to prescription errors, medication, procedures, adverse events (AEs) and medicines. This is a descriptive pilot study performed at the neonatal unit of a hospital in Maringá, characterization of the hospitalizations of patients in the NICU and the occurrence of AE recorded in medical records in a private hospital in Maringá from June 2016 to March 2017. Indicators were evaluated: mortality rates, occupation, permanence rates and occurrence of AE. Data were obtained from the nursing records in the medical records of hospitalized patients in the sector. A total of 607 adverse events were observed, of which 326 (53.70%) were procedures related to central venous access; 87(14.33%) central peripheral insertion catheter (PICC); 87(14.33%) to intubation; 45(7.41%) for delayed placement of the bladder catheter; and, 32(5.27%) for umbilical catheter, among others. Better monitoring of the sector should be encouraged to avoid the occurrence of AEs in-hospital procedures, pharmacotherapy, and drug interactions.

Descriptors: Intensive Care Unit, Neonatal, Adverse Events.

 

Caracterización de eventos adversos en una unidad de terapia intensiva neonatal

Resumen: Hay problemas en las unidades hospitalarias relacionadas con errores de prescripción, medicamentos, procedimientos, eventos adversos (EAs) y medicamentos. Se trata de un estudio piloto descriptivo realizado en la unidad neonatal de un hospital en Maringá, con caracterización de las hospitalizaciones de pacientes en la UCIN y la aparición de EA registrada en registros médicos en un hospital privado en Maringá desde junio de 2016 a marzo de 2017. Los indicadores fueron evaluados: tasas de mortalidad, ocupación, tasas de permanencia y ocurrencia de EA. Los datos se obtuvieron a partir de los registros de enfermería en los registros médicos de pacientes hospitalizados en el sector.Se observaron un total de 607 eventos adversos, 326 (un 53,70%) fueron procedimientos relacionados con el acceso venoso central; 87 (un 14,33%) catéter de inserción periférica central (PICC); 87 (un 14,33%) a la intubación; 45 (un 7,41%) por la colocación tardía del catéter vesical; y 32 (un 5.27%) para catéter umbilical, entre otros. Se debe alentar un mejor monitoreo del sector para evitar la ocurrencia de procedimientos intraoperatorios,

Descriptores: Unidad de Cuidados Intensivos, Neonatal, Eventos Adversos.

Texto completo:

PDF

Referências

UNICEF. United Nations Children’s Fund. Committing to Child Survival: A Promise Renewed. Progress Report UNICEF, New York, september 2013 [cited 2019 jan 20]. Available from: .

Tripathi N, Cotten CM, Smith B. Antibiotic use and misuse in the neonatal intensive care unit. Clin Perinato. 2012; 39(1):8.

WHO. The Conceptual Framework for the International Classification for Patient Safety. Final Technical Report and Technical Annexes, World Health Organization. 2009. [cited 2019 jan 21]. Available from: .

James S, Ito S. Neonatal pharmacology: rational terapeutics for the most vunerable. Clin Pharmacol Ther. 2009; 86(6):573-77.

Aagaard L, Christensen A, Hansen EH. Information about adverse drug reactions reported in children: a qualitative review of empirical studies. Br J Clin Pharmacol. 2010; 70(4):481-491. Available from: .

Woods D, Thomas E, Holl J, Altman S, Brennan T. Adverse events and preventable adverse events in children. Pediatrics. 2005; 115(1):155-60. Available from: .

Chien JY, Ho RJ. Drug delivery trends in clinical trials and translational medicine: evaluation of pharmacokinetic properties in special populations. J. Pharm. Sci 2011; 100(1):5358. Available from: .

O’Hara K, Wright IM, Schneider JJ, Jones AL, Martin JH. Pharmacokinetics in neonatal prescribing: evidence base, paradigms and the future. Br J Clin Pharmacol. 2015; 80(6). Available from: .

Leclen R. Les erreurs de prescriptions en neonatologie: incidence, types d'erreurs, detection et prevention. Archives Pediatrie. 2007; 14(1). Available from: .

Alomar MJ. Factors affecting the development of adverse drug reactions (Review article). Saudi Pharm J. 2014; 22(2):83-94. Available from: .

The Regulation (EC) No 1901/2006 of the European Parliament and of the Council of 12 December 2006 on medicinal products for paediatric use. Successes of the Paediatric Regulation after 5 years. 2006. [cited 2019 mar 12]. Available from: .

Sharek PJ, Horbar JD, Mason W, Bisarya H, Thurm CW, Suresh G, Gray, et al. Adverse events in the neonatal intensive care unit: development, testing, and findings of an NICU-focused trigger tool to identify harm in North American NICUs. Pediatrics. 2006; 118(4):1332-1340. Availble from: .

Takata GS, Mason W, Taketomo C, Logsdon T, Sharek PJ. Development, testing, and findings of a pediatric-focused trigger tool to identify medication-related harm in US children’s hospitals. Pediatrics. 2008; 121(4):e297–35. Available from: .


Visualizações do PDF:

8 views


Visualizações do Resumo:

33 views

Apontamentos

  • Não há apontamentos.
Copyright: ©-2014 Revista Recien - Revista Científica de Enfermagem. Todos os direitos reservados.
Tema: Mason Publishing Group. Customizado por: Articloud